84 related articles for article (PubMed ID: 34047432)
21. Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer.
Bradley MC; Zhou Y; Freedman AN; Yood MU; Quesenbery CP; Haque R; Van Den Eeden SK; Cassidy-Bushrow AE; Aaronson D; Potosky AL
Cancer Causes Control; 2018 Aug; 29(8):785-791. PubMed ID: 29959604
[TBL] [Abstract][Full Text] [Related]
22. Statin reduces the risk of dementia in diabetic patients receiving androgen deprivation therapy for prostate cancer.
Liu JM; Chen TH; Chuang HC; Wu CT; Hsu RJ
Prostate Cancer Prostatic Dis; 2019 May; 22(2):276-283. PubMed ID: 30337635
[TBL] [Abstract][Full Text] [Related]
23. Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation.
Hayes D; Patel AV; Black SM; McCoy KS; Kirkby S; Tobias JD; Mansour HM; Whitson BA
J Thorac Cardiovasc Surg; 2015 Sep; 150(3):707-13.e2. PubMed ID: 26208890
[TBL] [Abstract][Full Text] [Related]
24. Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes.
Tseng CH
Oncotarget; 2017 Mar; 8(12):19057-19064. PubMed ID: 27661113
[TBL] [Abstract][Full Text] [Related]
25. Outcomes of type A intramural hematoma: Influence of diabetes mellitus.
Chen Q; Jiang D; Kuang F; Yang F; Shan Z
J Card Surg; 2020 Aug; 35(8):1811-1821. PubMed ID: 32652723
[TBL] [Abstract][Full Text] [Related]
26. The Combined Impact of Chronic Kidney Disease and Diabetes on the Risk of Colorectal Cancer Depends on Sex: A Nationwide Population-Based Study.
Oh HJ; Lee HA; Moon CM; Ryu DR
Yonsei Med J; 2020 Jun; 61(6):506-514. PubMed ID: 32469174
[TBL] [Abstract][Full Text] [Related]
27. 5-alpha-reductase inhibitors and the risk of diabetes mellitus: A nationwide population-based study.
Lee SS; Yang YW; Tsai TH; Kuo YH; Chuang HY; Lee CC; Hsieh TF
Prostate; 2016 Jan; 76(1):41-7. PubMed ID: 26390988
[TBL] [Abstract][Full Text] [Related]
28. Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy.
Richards KA; Liou JI; Cryns VL; Downs TM; Abel EJ; Jarrard DF
J Urol; 2018 Dec; 200(6):1256-1263. PubMed ID: 29940252
[TBL] [Abstract][Full Text] [Related]
29. Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancer.
Young JWS; Sutradhar R; Rangrej J; Marras C; Fleshner N; Alibhai SMH
World J Urol; 2017 Sep; 35(9):1417-1423. PubMed ID: 28204918
[TBL] [Abstract][Full Text] [Related]
30. Risk of head and neck cancer in patients with diabetes mellitus: a retrospective cohort study in Taiwan.
Tseng KS; Lin C; Lin YS; Weng SF
JAMA Otolaryngol Head Neck Surg; 2014 Aug; 140(8):746-53. PubMed ID: 25058016
[TBL] [Abstract][Full Text] [Related]
31. Retrospective cohort study of androgen deprivation therapy and the risk of diabetes in men with prostate cancer in Lithuania.
Drevinskaite M; Patasius A; Kincius M; Urbonas V; Smailyte G
BMJ Open; 2021 Jul; 11(7):e045797. PubMed ID: 34321292
[TBL] [Abstract][Full Text] [Related]
32. Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan.
Chiu CC; Huang CC; Chen YC; Chen TJ; Liang Y; Lin SJ; Chen JW; Leu HB; Chan WL
Intern Med; 2013; 52(9):939-46. PubMed ID: 23648711
[TBL] [Abstract][Full Text] [Related]
33. Is diabetes mellitus associated with clinical outcomes in aging males treated with transurethral resection of prostate for bladder outlet obstruction: implications from Taiwan Nationwide Population-Based Cohort Study.
Lin YH; Hou CP; Chen TH; Juang HH; Chang PL; Yang PS; Lin YS; Chen CL; Tsui KH
Clin Interv Aging; 2017; 12():535-541. PubMed ID: 28356725
[TBL] [Abstract][Full Text] [Related]
34. History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States).
Chan JM; Latini DM; Cowan J; Duchane J; Carroll PR
Cancer Causes Control; 2005 Sep; 16(7):789-97. PubMed ID: 16132789
[TBL] [Abstract][Full Text] [Related]
35. Diabetes mellitus and prostate cancer risk.
Pierce BL; Plymate S; Ostrander EA; Stanford JL
Prostate; 2008 Jul; 68(10):1126-32. PubMed ID: 18459104
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant hormonal therapy use and the risk of death in men with prostate cancer treated with brachytherapy who have no or at least a single risk factor for coronary artery disease.
Nanda A; Chen MH; Moran BJ; Braccioforte MH; Dosoretz D; Salenius S; Katin M; Ross R; D'Amico AV
Eur Urol; 2014 Jan; 65(1):177-85. PubMed ID: 22981136
[TBL] [Abstract][Full Text] [Related]
37. Association Between Androgen Deprivation Therapy Use and Diagnosis of Dementia in Men With Prostate Cancer.
Jayadevappa R; Chhatre S; Malkowicz SB; Parikh RB; Guzzo T; Wein AJ
JAMA Netw Open; 2019 Jul; 2(7):e196562. PubMed ID: 31268539
[TBL] [Abstract][Full Text] [Related]
38. 5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer.
Azoulay L; Eberg M; Benayoun S; Pollak M
JAMA Oncol; 2015 Jun; 1(3):314-20. PubMed ID: 26181177
[TBL] [Abstract][Full Text] [Related]
39. The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series.
Moreira DM; Anderson T; Gerber L; Thomas JA; Bañez LL; McKeever MG; Hoyo C; Grant D; Jayachandran J; Freedland SJ
Cancer Causes Control; 2011 Jul; 22(7):977-83. PubMed ID: 21562753
[TBL] [Abstract][Full Text] [Related]
40. Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL.
Fukushima H; Masuda H; Kawakami S; Ito M; Sakura M; Numao N; Koga F; Saito K; Fujii Y; Yamamoto S; Yonese J; Fukui I; Kihara K
Urology; 2012 Jun; 79(6):1329-34. PubMed ID: 22656412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
